Chemical hypoxia in human pluripotent NT2 stem cell-derived neurons: Effect of hydroxamic acid and benzamide-based epigenetic drugs

Authors

  • Rushita A Bagchi Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Ashim K Bagchi Institute of Cardiovascular Sciences, St. Boniface Albrechtsen Research Centre, Winnipeg, Manitoba, Canada.
  • Ankita Salunke Department of Zoology, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India.
  • Dipak K Hens Sonamukhi College, The University of Burdwan, West Bengal, India.
  • Pragna H Parikh Department of Zoology, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India.

DOI:

https://doi.org/10.31117/neuroscirn.v2i3.30

Keywords:

pluripotent, neuron, hypoxia, histone deacetylase, gene expression

Abstract

Hypoxia-induced oxidative stress contributes to neuronal damage leading to many neurodegenerative disorders. Hypoxia promotes many downstream effectors such as hypoxia-inducible factor-1α (HIF-1α) in order to restore respiratory homeostasis due to low oxygen availability and increased ROS. Use of histone deacetylase (HDAC) inhibitors may modulate hypoxia-induced neuronal cell damage.  In this study, we used two chemically diverse HDAC inhibitors to investigate their effect on hypoxia-exposed neuronal cells. Human pluripotent NT-2 stem cell-derived neuronal differentiated cells were exposed to CoCl2 pre-treatment for 6h to induce hypoxia, prior to supplementation of HDAC inhibitor (SAHA or MGCD0103). Treatment with HDAC inhibitor improved cell viability in hypoxia-induced neuronal cells. The increased HIF1α expression in hypoxia-induced neuronal cells was blunted by these HDAC inhibitors with a concomitant decrease in ROS production. CoCl2 treatment caused an increase in IL-1β, which was significantly inhibited by these HDAC inhibitors. Furthermore, apoptosis induced in these CoCl2 treated neuronal cells was mitigated by SAHA as well MGCD0103 suggesting that these HDAC inhibitors are capable of reducing cellular toxicity, inflammation and apoptosis, and thus, could be beneficial as therapeutic molecules for many neuropathological conditions.

References

Adam-Vizi V. Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxid Redox Signal. 2005;7(9-10):1140-1149. https://doi.org/10.1089/ars.2005.7.1140

Alarifi S, Ali D, Omar Suliman Y Al, Ahamed M, Siddiqui MA, Al-Khedhairy AA. Oxidative stress contributes to cobalt oxide nanoparticles-induced cytotoxicity and DNA damage in human hepatocarcinoma cells. Int J Nanomedicine. 2013;8(10):189-199. https://doi.org/10.2147/IJN.S37924

Butler KV, Kalin J, Brochier C, Vistoli G, Langley B, Kozikowski AP. Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. J Am Chem Soc. 2010;132(31):10842-10846. https://doi.org/10.1021/ja102758v

DeGracia DJ, Kumar R, Owen CR, Krause GS, White BC. Molecular pathways of protein synthesis inhibition during brain reperfusion: implications for neuronal survival or death. J Cereb Blood Flow Metab. 2002;22(2):127-141. https://doi.org/10.1097/00004647-200202000-00001

Fournel M, Bonfils C, Hou Y, Yan PT, Trachy-Bourget M-C, Kalita A, et al. MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo. Mol Cancer Ther. 2008;7(4):759-768. https://doi.org/10.1158/1535-7163.MCT-07-2026

Haile Y, Fu W, Shi B, Westaway D, Baker G, Jhamandas J, et al. Characterization of the NT2-derived neuronal and astrocytic cell lines as alternative in vitro models for primary human neurons and astrocytes. J Neurosci Res. 2014;92(9):1187-1198. https://doi.org/10.1002/jnr.23399

Hardy M, Younkin D, Tang CM, Pleasure J, Shi QY, Williams M, et al. Expression of non-NMDA glutamate receptor channel genes by clonal human neurons. J Neurochem. 1994;63(2):482-489. https://doi.org/10.1046/j.1471-4159.1994.63020482.x

Hull EE, Montgomery MR, Leyva KJ. HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases. BioMed Research International. 2016;2016:8797206. https://doi.org/10.1155/2016/8797206

Langlois A, Duval D. Differentiation of the human NT2 cells into neurons and glia. Methods Cell Sci. 1997;19:213-219. https://doi.org/10.1023/A:1009731707443

Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, et al. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem. 1997;272(9):5375-5381. https://doi.org/10.33860/jbc.v1i1.186

Morrison BE, Majdzadeh N, Zhang X, Lyles A, Bassel-Duby R, Olson EN, et al. Neuroprotection by histone deacetylase-related protein. Molecular and Cellular Biology. 2006;26(9):3550-3564. https://doi.org/10.1128/MCB.26.9.3550-3564.2006

Movafagh S, Crook S, Vo K. Regulation of hypoxia-inducible factor-1a by reactive oxygen species: new developments in an old debate. J Cell Biochem. 2014;116(5):696-703. https://doi.org/10.1002/jcb.25074

Pistritto G, Papaleo V, Sanchez P, Ceci C, Barbaccia ML. Divergent modulation of neuronal differentiation by caspase-2 and -9. PLoS ONE. 2012;7(5):e36002. https://doi.org/10.1371/journal.pone.0036002

Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA. 1997;94(20):10925-10930. https://doi.org/10.1073/pnas.94.20.10925

Rangwala S, Zhang C, Duvic M. HDAC inhibitors for the treatment of cutaneous T-cell lymphomas. Future Med Chem. 2012;4(4):471-486. https://doi.org/10.4155/fmc.12.6

Sagulenko V, Vitak N, Vajjhala PR, Vince JE, Stacey KJ. Caspase-1 Is an Apical Caspase Leading to Caspase-3 Cleavage in the AIM2 Inflammasome Response, Independent of Caspase-8. J Mol Biol. 2017;430(2):238-247. https://doi.org/10.1016/j.jmb.2017.10.028

Samanta D, Prabhakar NR, Semenza GL. Systems biology of oxygen homeostasis. Wiley Interdiscip Rev Syst Biol Med. 2017;9(4). https://doi.org/10.1002/wsbm.1382

Schweizer S, Meisel A, Märschenz S. Epigenetic mechanisms in cerebral ischemia. J Cereb Blood Flow Metab. 2013;33(9):1335-1346. https://doi.org/10.1038/jcbfm.2013.93

Sebastián VP, Salazar GA, Coronado-Arrázola I, Schultz BM, Vallejos OP, Berkowitz L, et al. Heme Oxygenase-1 as a Modulator of Intestinal Inflammation Development and Progression. Front Immunol. 2018;9:1956. https://doi.org/10.3389/fimmu.2018.01956

Semenza GL. Hypoxia-inducible factor 1 and cardiovascular disease. Annu Rev Physiol. 2013;76:39-56. https://doi.org/10.1146/annurev-physiol-021113-170322

Semenza GL. Transcriptional regulation by hypoxia-inducible factor 1 molecular mechanisms of oxygen homeostasis. Trends Cardiovasc Med. 1996;6(5):151-157. https://doi.org/10.1016/1050-1738(96)00039-4

Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, et al. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 2012;339(6116):211-214. https://doi.org/10.1126/science.1227166

Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol (Lond). 2003;552(Pt 2):335-344. https://doi.org/10.1113/jphysiol.2003.049478

Unal-Cevik I, Kilinç M, Can A, Gürsoy-Ozdemir Y, Dalkara T. Apoptotic and necrotic death mechanisms are concomitantly activated in the same cell after cerebral ischemia. Stroke. 2004;35(9):2189-2194. https://doi.org/10.1161/01.STR.0000136149.81831.c5

Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009;7(1):65-74. https://doi.org/10.2174/157015909787602823

Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA. 1995;92(12):5510-5514. https://doi.org/10.1073/pnas.92.12.5510

Younkin DP, Tang CM, Hardy M, Reddy UR, Shi QY, Pleasure SJ, et al. Inducible expression of neuronal glutamate receptor channels in the NT2 human cell line. Proc Natl Acad Sci USA. 1993;90(6):2174-2178. https://doi.org/10.1073/pnas.90.6.2174

Zhang X, Yuan Z, Zhang Y, Yong S, Salas-Burgos A, Koomen J, et al. HDAC6 modulates cell motility by altering the acetylation level of cortactin. Neuroimage. 2007;27(2):197-213. https://doi.org/10.1016/j.molcel.2007.05.033

Zhao R, Feng J, He G. Hypoxia increases Nrf2-induced HO-1 expression via the PI3K/Akt pathway. Front Biosci (Landmark Ed). 2016;21:385-396. https://www.ncbi.nlm.nih.gov/pubmed/26709780

Ziemka-Nalecz M, Zalewska T. Neuroprotective effects of histone deacetylase inhibitors in brain ischemia. Acta Neurobiol Exp (Wars). 2015;74(4):383-395. https://www.ncbi.nlm.nih.gov/pubmed/25576969

Neuroscience Research Notes: Regular Issue

Downloads

Published

2019-08-22

How to Cite

Bagchi, R. A., Bagchi, A. K., Salunke, A., Hens, D. K. and Parikh, P. H. (2019) “Chemical hypoxia in human pluripotent NT2 stem cell-derived neurons: Effect of hydroxamic acid and benzamide-based epigenetic drugs”, Neuroscience Research Notes, 2(3), pp. 12–19. doi: 10.31117/neuroscirn.v2i3.30.

Issue

Vol. 2 No. 3 (2019)

Section

Research Notes

License

Copyright (c) 2019 Rushita A Bagchi, Ashim K Bagchi, Ankita Salunke, Dipak K Hens, Pragna H Parikh

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

The observations and associated materials published or posted by NeurosciRN are licensed by the authors for use and distribution in accord with the Creative Commons Attribution license CC BY-NC 4.0 international, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.